Coppell Advisory Solutions »

Lexicon Pharmaceuticals shares owned by Coppell Advisory Solutions

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Coppell Advisory Solutions from 13F filings

Historical chart of Coppell Advisory Solutions investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Coppell Advisory Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Coppell Advisory Solutions

Quarter filed Position value Share count Share price at filing
2024-09-30 $83 52 1.60
2024-06-30 $87 52 1.67
2023-12-31 $80 52 1.54
2023-09-30 $215 113 1.91
2023-06-30 $113 52 2.17
2022-12-31 $215 113 1.91

More positions owned by Coppell Advisory Solutions

First Tr Exchange Traded Fd Vi Tcw Opportunis Etf Fixd (FIXD)
First Tr Exchange Traded Fd Iv First Tr Enh New Etf FTSM (FTSM)
Tesla Tsla (TSLA)
Kingsmen Resources Ord KNG (KNG)
Walmart WMT (WMT)
Oracle Corp Orcl (ORCL)
Unitedhealth Group Unh (UNH)
Spdr Series Trust Spdr Bloomberg Etf Bil (BIL)
First Tr Exchange Traded Fd Vi Ft Cboe Vest U S Eq Bufer S Bufr (BUFR)
SPDR S&P 500 ETF Trust Spy (SPY)
Etf Series Solutions Aam Lw Dur Pfd Etf PFLD (PFLD)
Ft Cboe Vest Fund Of Deep Buffer Etf Bufd (BUFD)
First Tst Value Li Shs Etf FVD (FVD)
Microsoft Corp MSFT (MSFT)
Apple Aapl (AAPL)

View all positions for Coppell Advisory Solutions

Top funds holding Lexicon Pharmaceuticals

Artal Group
FMR
Siren
BlackRock
Vanguard Group
Point72 Asset Management
Schonfeld Strategic Advisors
Nantahala Capital Management
Geode Capital Management
State Street Corporation
NEA Management Company
Ikarian Capital
Gail Mannix
Northern Trust
Charles Schwab Investment Management

View all funds holding Lexicon Pharmaceuticals